These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19948247)

  • 21. Outcome with Primary En-bloc Esophagectomy for Submucosal Esophageal Adenocarcinoma.
    Schwameis K; Green KM; Worrell SG; Samaan J; Cooper S; Tatishchev S; Oh DS; Hagen JA; DeMeester SR
    Ann Surg Oncol; 2017 Dec; 24(13):3921-3925. PubMed ID: 28975518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The overall metastatic rate in early esophageal adenocarcinoma: long-time follow-up of surgically treated patients.
    Oetzmann von Sochaczewski C; Haist T; Pauthner M; Mann M; Fisseler-Eckhoff A; Braun S; Ell C; Lorenz D
    Dis Esophagus; 2019 Nov; 32(9):. PubMed ID: 30596900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
    Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
    Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes.
    Davison JM; Landau MS; Luketich JD; McGrath KM; Foxwell TJ; Landsittel DP; Gibson MK; Nason KS
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):369-377.e3. PubMed ID: 26515637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
    Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
    World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular markers predicting lymph node metastasis in early esophageal cancer.
    Plum PS; Warnecke-Eberz U; Dhaouadi O; Alakus H; Drebber U; Metzger R; Prenzel KL; Hölscher AH; Bollschweiler E
    Histol Histopathol; 2015 Oct; 30(10):1193-202. PubMed ID: 25869644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns.
    Manner H; Pech O; Heldmann Y; May A; Pauthner M; Lorenz D; Fisseler-Eckhoff A; Stolte M; Vieth M; Ell C
    Surg Endosc; 2015 Jul; 29(7):1888-96. PubMed ID: 25294553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depth of
    Seder CW; Mahon B; Hennon M; Thomas M; Levea CM; Matkowskyj KA; Krishna M; Medairos R; Macke RA; Basu S; Blasberg JD
    Anticancer Res; 2018 Apr; 38(4):2195-2200. PubMed ID: 29599339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of lymphovascular invasion in lymph node-negative superficial esophageal squamous cell carcinoma.
    Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K; Makuuchi H; Ogura G
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30883635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node metastasis in early esophageal adenocarcinoma.
    Griffin SM; Burt AD; Jennings NA
    Ann Surg; 2011 Nov; 254(5):731-6; discussion 736-7. PubMed ID: 21997815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction.
    Westerterp M; Koppert LB; Buskens CJ; Tilanus HW; ten Kate FJ; Bergman JJ; Siersema PD; van Dekken H; van Lanschot JJ
    Virchows Arch; 2005 May; 446(5):497-504. PubMed ID: 15838647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis.
    Araki K; Ohno S; Egashira A; Saeki H; Kawaguchi H; Sugimachi K
    Cancer; 2002 Jan; 94(2):570-5. PubMed ID: 11900242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endoscopic evaluation of the depth of invasion in cases of superficial esophageal cancer in determining indications for endoscopic mucosal resection].
    Yoshida M; Momma K
    Nihon Geka Gakkai Zasshi; 2002 Apr; 103(4):337-42. PubMed ID: 11993221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.
    Buskens CJ; Westerterp M; Lagarde SM; Bergman JJ; ten Kate FJ; van Lanschot JJ
    Gastrointest Endosc; 2004 Nov; 60(5):703-10. PubMed ID: 15557945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Lymph Node Metastasis in Patients with the Superficial Spreading Type of Esophageal Squamous Cell Carcinoma.
    Yachida T; Oda I; Abe S; Sekiguchi M; Nonaka S; Suzuki H; Yoshinaga S; Taniguchi H; Sekine S; Masugata H; Masaki T; Daiko H; Saito Y
    Digestion; 2020; 101(3):239-244. PubMed ID: 30909271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial carcinoma of the thoracic esophagus.
    Kato H; Tachimori Y; Mizobuchi S; Igaki H; Ochiai A
    Cancer; 1993 Nov; 72(10):2879-82. PubMed ID: 8221552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients.
    Akutsu Y; Uesato M; Shuto K; Kono T; Hoshino I; Horibe D; Sazuka T; Takeshita N; Maruyama T; Isozaki Y; Akanuma N; Matsubara H
    Ann Surg; 2013 Jun; 257(6):1032-8. PubMed ID: 23108117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasion of poorly differentiated adenocarcinoma to the deep muscularis mucosae may be an indicator of lymph node metastasis in Barrett's esophageal cancer.
    Sakaguchi Y; Ono S; Fujishiro M; Yamamichi N; Koike K
    Dig Endosc; 2013 May; 25 Suppl 2():168-72. PubMed ID: 23617671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Esophageal adenocarcinoma: the clinicopathologic features, patterns of lymph node metastasis and its influencing factors].
    Wang J; Li N; Wang XF; Jing SW; Yang CR; Wang Y; Cao F; Jiao WP; Wu YJ; Guo Y
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):515-20. PubMed ID: 27531265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.